Copyright
©2007 Baishideng Publishing Group Co.
World J Gastroenterol. Jul 28, 2007; 13(28): 3836-3840
Published online Jul 28, 2007. doi: 10.3748/wjg.v13.i28.3836
Published online Jul 28, 2007. doi: 10.3748/wjg.v13.i28.3836
Table 2 Eradication rate of H pylori
| Lafutidine group | Lansoprazole group | P | ||
| Intention-to-treat analysis | ||||
| No. of patients | 24 | 22 | - | |
| Eradication rate | 16/24 (66.7%) | 16/22 (72.7%) | NS | |
| Per-protocol analysis | ||||
| No. of patients | 20 | 20 | - | |
| Eradication rate | 14/20 (70.0%) | 14/20 (70.0%) | NS | |
-
Citation: Hagiwara T, Kato M, Anbo T, Imamura A, Suga T, Uchida T, Fujinaga A, Nakagawa M, Nakagawa S, Shimizu Y, Yamamoto J, Takeda H, Asaka M. Improvement in symptoms after H2-receptor antagonist-based therapy for eradication of
H pylori infection. World J Gastroenterol 2007; 13(28): 3836-3840 - URL: https://www.wjgnet.com/1007-9327/full/v13/i28/3836.htm
- DOI: https://dx.doi.org/10.3748/wjg.v13.i28.3836